Cargando…

Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo

OBJECTIVE: Although our previous studies have confirmed that 1, 3, 8-trihydroxy-6-methylant hraquinone (emodin) inhibits migration and invasion in epithelial ovarian cancer (EOC) cells, the underlying molecular mechanism remains unknown. Here, the aim was to investigate the effects of emodin on EOC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Jingjing, Xu, Ying, Zhao, Zhe, Ke, Xiaoning, Wei, Xuan, Kang, Jia, Zong, Xuan, Mao, Hongluan, Liu, Peishu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530856/ https://www.ncbi.nlm.nih.gov/pubmed/28790850 http://dx.doi.org/10.2147/OTT.S138217

Ejemplares similares

Emodin Suppresses Proliferation, Migration and Invasion in Ovarian Cancer Cells by down Regulating ILK in vitro and in vivo [Retraction]
Publicado: (2022)

Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3β/Slug Signaling Pathway
por: Lu, Jingjing, et al.
Publicado: (2016)

MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP
por: Pang, Yingxin, et al.
Publicado: (2014)

ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo
por: Li, Rui, et al.
Publicado: (2019)

Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis
por: Zhang, Xue, et al.
Publicado: (2021)

Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo
por: Zhang, Xiaolei, et al.
Publicado: (2020)

Low Density Lipoprotein Receptor (LDLR) and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (HMGCR) Expression are Associated with Platinum-Resistance and Prognosis in Ovarian Carcinoma Patients
por: Huang, Xueyao, et al.
Publicado: (2021)

Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer
por: Luan, Wenqing, et al.
Publicado: (2019)

Emodin Reverses the Epithelial–Mesenchymal Transition of Human Endometrial Stromal Cells by Inhibiting ILK/GSK-3β Pathway
por: Zheng, Qiaomei, et al.
Publicado: (2020)

Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ERα Inhibition
por: Huang, Pao-Hsuan, et al.
Publicado: (2013)

The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer
por: Pang, Yingxin, et al.
Publicado: (2022)

Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2020)

Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway
por: Wei, Xuan, et al.
Publicado: (2021)

Development of Nomogram Models Based on Peripheral Blood Score and Clinicopathological Parameters to Predict Preoperative Advanced Stage and Prognosis for Epithelial Ovarian Cancer Patients
por: Bai, Gaigai, et al.
Publicado: (2023)

Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway
por: Wei, Xuan, et al.
Publicado: (2021)

Emodin inhibits the proliferation and migration of B16F10 cells and induces their apoptosis
por: Yuan, Mingjie, et al.
Publicado: (2020)

Silencing of ILK attenuates the abnormal proliferation and migration of human Tenon's capsule fibroblasts induced by TGF-β2
por: Xing, Yao, et al.
Publicado: (2016)

Parvin-ILK: An intimate relationship
por: Vakaloglou, Katerina, et al.
Publicado: (2012)

Successful pregnancy following conservative management of low-grade endometrial stromal sarcoma: A case report
por: DONG, RUIYING, et al.
Publicado: (2014)

MicroR-542-3p can mediate ILK and further inhibit cell proliferation, migration and invasion in osteosarcoma cells
por: Cai, Wei, et al.
Publicado: (2019)

GABPA Expression in Endometrial Carcinoma: A Prognostic Marker
por: Ma, Xiaoxue, et al.
Publicado: (2021)

ILK Induces Cardiomyogenesis in the Human Heart
por: Traister, Alexandra, et al.
Publicado: (2012)

The Impairment of ILK Related Angiogenesis Involved in Cardiac Maladaptation after Infarction
por: Xie, Jun, et al.
Publicado: (2011)

Suppression of SMOC2 alleviates myocardial fibrosis via the ILK/p38 pathway
por: Rui, Huang, et al.
Publicado: (2023)

Emodin as an Inhibitor of PRV Infection In Vitro and In Vivo
por: Cai, Xiaojing, et al.
Publicado: (2023)

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit
por: Hou, Yue, et al.
Publicado: (2023)

Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury
por: YAN, GAOLIANG, et al.
Publicado: (2015)

Emodin Suppresses Hyperglycemia-Induced Proliferation and Fibronectin Expression in Mesangial Cells via Inhibiting cFLIP
por: Gao, Junjie, et al.
Publicado: (2014)

Periostin Facilitates the Epithelial-Mesenchymal Transition of Endometrial Epithelial Cells through ILK-Akt Signaling Pathway
por: Zheng, Qiao-mei, et al.
Publicado: (2016)

Cerebroprotective effect of Aloe Emodin: In silico and in vivo studies
por: Pasala, Praveen Kumar, et al.
Publicado: (2022)

Emodin Suppresses Migration and Invasion through the Modulation of CXCR4 Expression in an Orthotopic Model of Human Hepatocellular Carcinoma
por: Manu, Kanjoormana Aryan, et al.
Publicado: (2013)

Forced Degradation Studies of Aloe Emodin and Emodin by HPTLC
por: Narayanan, Sindhu, et al.
Publicado: (2015)

The Comparison of the Efficiency of Emodin and Aloe-Emodin in Photodynamic Therapy
por: Nowak-Perlak, Martyna, et al.
Publicado: (2022)

Emodin inhibits the proliferation of papillary thyroid carcinoma by activating AMPK
por: Li, Weilong, et al.
Publicado: (2021)

Aloe-emodin inhibits the proliferation, migration, and invasion of melanoma cells via inactivation of the Wnt/beta-catenin signaling pathway
por: Du, Maotao, et al.
Publicado: (2021)

In vitro and in vivo antileishmanial effects of aloe-emodin on Leishmania major
por: Dalimi, Abdolhossein, et al.
Publicado: (2015)

Emodin enhances osteogenesis and inhibits adipogenesis
por: Yang, Feng, et al.
Publicado: (2014)

Design and Synthesis of Novel Anti-Proliferative Emodin Derivatives and Studies on their Cell Cycle Arrest, Apoptosis Pathway and Migration
por: Yang, Kun, et al.
Publicado: (2019)

Emodin Attenuates Lipopolysaccharide-Induced Acute Liver Injury via Inhibiting the TLR4 Signaling Pathway in vitro and in vivo
por: Ding, Yan, et al.
Publicado: (2018)

Integrin-linked kinase (ILK) expression in human colon cancer
por: Bravou, V, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_miug5urmg4bm0dh0oui44a8682